These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3594402)

  • 1. Prognostic significance of flow cytometry in lung cancer. A 5-year study.
    Tirindelli-Danesi D; Teodori L; Mauro F; Modini C; Botti C; Cicconetti F; Stipa S
    Cancer; 1987 Aug; 60(4):844-51. PubMed ID: 3594402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung.
    Sahin AA; Ro JY; el-Naggar AK; Lee JS; Ayala AG; Teague K; Hong WK
    Cancer; 1990 Feb; 65(3):530-7. PubMed ID: 2153432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance].
    Liewald F; Sunder-Plassmann L; Valet G; Wulf G; Weiss M; Schildberg FW
    Chirurg; 1992 Mar; 63(3):205-10. PubMed ID: 1313755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer.
    Isobe H; Miyamoto H; Shimizu T; Haneda H; Hashimoto M; Inoue K; Mizuno S; Kawakami Y
    Cancer; 1990 Mar; 65(6):1391-5. PubMed ID: 2155055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of the DNA ploidy pattern of primary lung cancer--its prognostic and biological implications].
    Shiba M; Yamaguchi Y
    Nihon Rinsho; 1992 Oct; 50(10):2395-400. PubMed ID: 1447809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneity.
    Teodori L; Tirindelli-Danesi D; Mauro F; De Vita R; Uccelli R; Botti C; Modini C; Nervi C; Stipa S
    Cytometry; 1983 Sep; 4(2):174-83. PubMed ID: 6313307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometric analysis of nuclear DNA content of lung cancer--correlation between nuclear DNA content and tumor doubling time].
    Usuda K; Saito Y; Aikawa H; Sakurada A; Chen Y; Takahashi S; Kanma K; Sato M; Sagawa M; Fujimura S
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):486-91. PubMed ID: 8035066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of DNA ploidy in primary non-small cell carcinoma of the lung in Korea.
    Cheon SH; Sohn HY; Chang J; Kim SK; Ko EH; Kim SK; Lee WY; Lee DY; Shin DH; Jeong ET
    Yonsei Med J; 1993 Dec; 34(4):365-70. PubMed ID: 8128742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of deoxyribonucleic acid aneuploidy in primary non-small-cell lung carcinomas and their metastases.
    Liewald F; Hatz R; Storck M; Orend KH; Weiss M; Wulf G; Valet G; Sunder-Plassmann L
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1476-82. PubMed ID: 1331622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O; Halvorsen OJ; Skjaerven R; Stangeland L; Gulsvik A; Laerum OD
    Anticancer Res; 1993; 13(3):571-8. PubMed ID: 8391242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment. Prognostic implications.
    Salvati F; Teodori L; Gagliardi L; Signora M; Aquilini M; Storniello G
    Chest; 1989 Nov; 96(5):1092-8. PubMed ID: 2553342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA index in the prognosis of colorectal cancer.
    Giaretti W; Danova M; Geido E; Mazzini G; Sciallero S; Aste H; Scivetti P; Riccardi A; Marsano B; Merlo F
    Cancer; 1991 Apr; 67(7):1921-7. PubMed ID: 2004305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of human lung cancer. Correlation with histologic type and stage.
    Moran RE; Melamed MR
    Anal Quant Cytol; 1984 Jun; 6(2):99-104. PubMed ID: 6205621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric DNA content analysis in neuroendocrine carcinoma of the lung. Correlation with survival and histologic subtype.
    Jackson-York GL; Davis BH; Warren WH; Gould VE; Memoli VA
    Cancer; 1991 Jul; 68(2):374-9. PubMed ID: 1648996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population.
    Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
    Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proliferative activity assessed on the basis of DNA ploidy patterns in primary lung cancer].
    Yamaoka N; Tagawa Y; Miyashita K; Ayabe H; Kawahara K; Uchiyama Y; Tomita M
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):598-602. PubMed ID: 1875901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.